Rivotril drops

Quick links to important sections

Rivotril drops

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Rivotril drops

Property Description
Active ingredient Clonazepam
Form Oral solution (drops)
Pharmacological class Benzodiazepine / Anticonvulsant
General purpose Neural stabilization
Origin Synthetic compound

Clonazepam: Classification and Identity of the Active Ingredient

Rivotril drops are fundamentally a single-ingredient medication containing the active ingredient Clonazepam. This compound is synthetic in origin and is classified within the Benzodiazepine pharmacological class, a group of medications that act as Central Nervous System (CNS) depressants. Clonazepam is globally clinically recognized for its potent stabilizing effects, distinguishing its profile as an effective anticonvulsant. Clonazepam is indicated for specific neurological conditions requiring CNS stabilization, validating its fundamental action in controlling neural overactivity.


Rivotril Oral Drops: Composition and Form Differentiation

The medication is supplied as an oral solution, commonly referred to as drops, a specific pharmaceutical preparation intended for administration via the oral route. This formulation consists of the active ingredient Clonazepam fully dissolved within a clear liquid vehicle. This preparation is distinguished because the liquid form allows for highly precise and incremental adjustments to the dose, a critical feature for managing conditions that require fine tuning of the medication level. The oral drops are particularly suitable for sensitive patient groups, such as pediatric patients, who may require very small, exact volumes or who cannot easily swallow conventional solid dosage forms.


General Therapeutic Purpose of Clonazepam

The overall purpose of the medication is to provide a stabilizing influence by enhancing the brain’s own inherent calming systems. Clonazepam achieves this by facilitating the action of gamma-aminobutyric acid (GABA), the brain's major inhibitory neurotransmitter. This physiological action directly contributes to controlling electrical overactivity in the central nervous system. The resulting general benefit is the relief of issues stemming from chronic neural hyperactivity, promoting overall neurological balance.

What side effects are possible with Rivotril drops?

The safety profile of Clonazepam, the active ingredient in Rivotril drops, is established through regulatory classifications that organize adverse reactions by frequency and physiological system.

Frequency and System-Organ Classifications

The most frequently documented adverse effects relate to the drug's action as a Central Nervous System (CNS) depressant. These effects are often most noticeable at the start of treatment or during dose adjustments and may lessen over time.

Frequency Classification Examples (SOC: Nervous System / Psychiatric)
Very Common Drowsiness (Somnolence)
Common Ataxia (impaired coordination), Dizziness, Fatigue, Muscle weakness, Confusional state
Uncommon Nervousness, Memory impairment (Anterograde amnesia), Nystagmus

Serious Adverse Reactions and Safety Constraints

Official regulatory documents detail specific serious adverse reactions. These include the risk of respiratory depression, particularly when combined with other CNS depressants, and the potential for drug dependence with subsequent withdrawal syndrome following prolonged use. Paradoxical reactions, such as acute excitement or aggression, are also officially documented.

Safety constraints mandate specific caution for certain populations. The medicine is officially contraindicated in severe hepatic impairment. Additionally, older adults may exhibit increased sensitivity to the CNS depressant effects, and pediatric patients require specific monitoring for increased salivation and bronchial hypersecretion.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Clonazepam is officially documented as primarily causing central nervous system (CNS) depression. The typical manifestations listed in regulatory information include somnolence (drowsiness), confusion, ataxia (impaired coordination), and dysarthria (slurred speech).

Serious Manifestations and Risk Factors

While overdose of Clonazepam alone is seldom life-threatening, the risk of a severe outcome increases significantly when co-ingested with other CNS depressants, notably alcohol and opioids. Severe presentations may lead to profound sedation, respiratory depression, hypotension, coma, and cardiovascular collapse. These serious effects may result in death.

Elderly patients and individuals with pre-existing respiratory conditions are officially noted as having an increased risk of severe outcomes, such as exacerbated respiratory depression.

Regulatory Action and Management

Regulatory authorities mandate that immediate medical attention must be sought for any suspected overdose. Emergency services must be contacted immediately if signs of severe CNS depression are present, such as slow or shallow breathing, or an inability to stay awake.

Official management strategies are primarily symptomatic and supportive treatment, focusing on maintaining adequate ventilation. The benzodiazepine antagonist Flumazenil is available; however, its use is generally not recommended in patients receiving prolonged Clonazepam therapy, as it carries a risk of precipitating convulsions.

Therapeutic Uses of Rivotril drops

The purpose of this medication is to provide neurological stabilization, primarily applied across domains where additional symptomatic support is needed in disorders characterized by sudden, excessive neuronal activity and intense episodes of distress. The medicine is commonly used to help with certain seizure disorders and panic disorder.

This medicine is used for managing conditions that present with disruptive symptom manifestations, notably: absence seizures, myoclonic seizures, and the complex manifestations of Lennox-Gastaut syndrome in the domain of epilepsy, alongside the symptomatic support for acute panic disorder. It is also considered relevant for easing challenging involuntary muscle movements (myoclonus) and severe, refractory Restless Legs Syndrome. The overall goal is to address symptom clusters that may become intense or disruptive. The symptomatic relief assists patients in coping more steadily with difficult and recurrent episodes. This supportive action is relevant when symptoms become temporarily overwhelming.


Quick Fact: Support for Episodic Distress

The medication helps manage symptoms related to heightened physiological activity and is commonly used across conditions presenting with acute episodes, contributing to easing the overall symptom load when symptoms are more noticeable.

Eligibility and Restrictions for Use

Who Can and Cannot Use Rivotril Drops?

Eligibility to use Rivotril (clonazepam) drops is determined by official regulatory criteria, primarily based on the patient’s health status, age, and physiological condition. This information reflects documented rules from government health authorities and prescribing labels.

Absolute Non-Eligibility (Contraindications)

This medicine must not be used by patients with:

  • Hypersensitivity to clonazepam or any other benzodiazepine.
  • Severe Hepatic Impairment or significant liver disease, due to the risk of precipitating hepatic encephalopathy.
  • Acute Narrow-Angle Glaucoma.

Eligibility by Age Group

Population Eligibility Status
Adults (16+) Established for approved indications.
Pediatric Patients Established for seizure disorders, suitable for precise dosing.
Elderly Patients Use is restricted; requires the lowest possible starting dose due to increased sensitivity.

Conditional and Restricted Use

Use of the drops requires caution or dose adjustment in several specific populations, including those with impaired renal function or chronic respiratory insufficiency. The use of this medicine during pregnancy is restricted, requiring a formal risk-benefit assessment, and use while breastfeeding is not recommended as the active ingredient passes into breast milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Rivotril drops is defined by two primary pharmacological domains: additive Central Nervous System (CNS) effects and hepatic metabolism modulation.

Interaction Type Interacting Substance/Class Official Outcome Description
Pharmacodynamic CNS Depressants (Opioids, Alcohol) Additive depressant effect; risk of profound sedation and respiratory depression.
Pharmacokinetic CYP3A4 Inducers (e.g., Carbamazepine) Reduction in Clonazepam plasma concentration (up to 38% reduction reported).
Pharmacokinetic CYP3A4 Inhibitors (e.g., certain Antifungals) Risk of exaggerated concentrations due to impaired metabolism.

Concomitant use with other CNS depressants, notably Opioids, carries a strong regulatory warning due to a pharmacodynamic interaction that may result in profound sedation, respiratory depression, coma, and death. Co-consumption of Alcohol must be avoided for the same reason.

In terms of pharmacokinetic interactions, Clonazepam is metabolized primarily by the CYP3A4 enzyme system. Co-administration with enzyme inducers, such as Carbamazepine and Phenytoin, may cause a reduction in Clonazepam plasma concentrations. Conversely, co-administration with CYP3A4 inhibitors may increase drug exposure, leading to the risk of exaggerated concentrations. For diet, consumption of Grapefruit Juice should be avoided as it may increase the drug’s blood levels. Regulatory documents also note a population-specific constraint: in patients with hepatic impairment, drug elimination may be impaired due to reliance on hepatic metabolism.

Mechanism of Action

Clonazepam, the active pharmaceutical ingredient in Rivotril drops, distributes rapidly to the central nervous system, crossing the blood-brain barrier. Its primary biological target is the GABA A receptor complex, which is a ligand-gated chloride ion channel. Clonazepam functions as a positive allosteric modulator of this receptor. It binds to a distinct benzodiazepine-binding site located between the alpha and gamma subunits of the receptor, an area separate from the endogenous gamma-aminobutyric acid ( GABA) binding site.

This binding induces a conformational change in the receptor protein, which enhances the affinity of the GABA receptor for the GABA neurotransmitter. The molecular pathway modification results in an increase in the frequency of chloride ion channel opening.

The increased influx of negatively charged chloride ions across the postsynaptic neuronal membrane causes hyperpolarization of the neuron. This intracellular consequence elevates the neuronal firing threshold, leading to a reduction in overall neuronal excitability. The resulting downstream cascade is a pervasive enhancement of GABAergic inhibitory neurotransmission throughout the central nervous system. This system-level physiological consequence includes a generalized reduction of excessive or synchronous electrical nerve activity.

Dosage and Administration Information

Rivotril oral solution (drops) containing the active substance clonazepam must be used exactly as prescribed by a healthcare provider. The dose, frequency, and duration of treatment are determined individually based on age, weight, and the medical condition being treated.

Administration Instructions

The drops are dispensed from the bottle using the dropper secured in the neck. Careful measurement is essential for safety, as incorrect dosing can easily lead to overdose.

  • Do not administer the drops directly into the mouth from the bottle.
  • The prescribed number of drops must be counted onto a spoon or into a small cup/oral dispenser.
  • The drops can be taken directly from the spoon or mixed with a small amount of water, tea, or fruit juice immediately before use.

Dosing Information

The drops typically contain 2.5 mg of clonazepam per milliliter (mL), where 1 drop is equivalent to 0.1 mg of clonazepam. Your starting dose is usually low and may be increased gradually by your doctor every few days to reach the optimal maintenance dose. Doses are often divided and taken two or three times per day. If the doses are not equally divided, the largest portion may be taken at bedtime to manage potential drowsiness.

Important Safety Note

  • Take this medicine at approximately the same time each day. If a dose is missed, take it as soon as you remember, unless it is almost time for the next scheduled dose; in that case, skip the missed dose. Never take a double dose to compensate for a forgotten one.
  • Treatment must not be stopped abruptly. Abrupt discontinuation, like with all anti-epileptic medicines, can lead to severe withdrawal symptoms or an increase in seizures. Your doctor will provide instructions for a slow, gradual reduction of the dose.
Drop-to-Milligram Conversion
1 Drop 0.1 mg (100 micrograms)
10 Drops 1.0 mg
25 Drops 2.5 mg (1 mL)

Recent Clinical Evidence

Research Evidence / Overview of Studies for Rivotril drops

Evidence for use in Major Depressive Disorder (MDD)

Research examining MDD primarily involves short-term controlled trials that were conducted during periods of increased symptom activity in adults. These studies explored how symptoms change over time and measured outcomes reflecting daily functioning and overall severity, using standardized rating scales. Findings describe patterns observed in these time-limited studies, detailing changes in depressive symptom intensity over a few weeks or months.

The medication was evaluated in studies involving adults diagnosed with unipolar MDD, including some individuals for whom prior treatments had not been sufficient. Studies monitored measurements of symptom severity ratings during the defined trial periods. However, research exploring short-term symptom changes does not determine whether an individual will respond similarly. Uncertainty remains regarding the long-term patterns and sustained changes beyond the study duration. Long-term effects are not fully established, and data for certain groups remain insufficient.


Evidence for use in Generalized Anxiety Disorder (GAD)

Research on GAD was studied for in short-term randomized trials and observational studies, typically involving adult patients. This research explored outcomes related to systemic or functional imbalance and outcomes describing episodic or acute changes in anxiety severity. Findings describe patterns observed in the studies conducted during periods of increased symptom activity, particularly highlighting changes measured during the short-term study period. Comparative evidence is lacking, and data for certain groups remain insufficient, especially for those with complex co-occurring medical conditions.


Evidence for use in Chronic Pain Syndrome

Studies exploring chronic pain was evaluated in controlled trials involving patients with specific types of neuropathic pain. These studies explored outcomes related to physical discomfort, monitoring subjective pain intensity using patient-reported scales. Findings describe patterns observed in the studies, where research highlights changes measured in subjective pain intensity over short timeframes (typically 4 to 12 weeks). A key limitation is that follow-up durations were limited relative to the chronic nature of the condition, and evidence is limited for many types of chronic pain beyond the specific neuropathic conditions studied.


What is still uncertain about Rivotril drops

Across the body of research, a consistent limitation is that long-term effects are not fully established for any of the indications studied. Follow-up durations were limited in many controlled trials, and comparative evidence is lacking to fully contextualize the findings against other available options. Sample sizes were modest in various studies, and data for certain groups remain insufficient, leaving gaps in understanding how outcomes may vary across the lifespan or in patients with specific health challenges.

Key Studies & References

  1. Treatment of Neuropathic Pain - Mechanisms of Vascular Disease (NCBI Bookshelf)
  2. Clonazepam - StatPearls (NCBI Bookshelf)

Frequently Asked Questions (FAQ)

Common questions about Rivotril drops (FAQ)

Q: What is the main reason Rivotril drops are prescribed?

A: Official documents state that the active substance, clonazepam, is indicated for the treatment of certain seizure disorders in adults and children. These conditions include specific types of seizures such as akinetic, myoclonic, and absence seizures.


Q: Is Rivotril drops the same medicine as Clonazepam?

A: Rivotril is the brand name for the medicine, and Clonazepam is the name of the active pharmaceutical ingredient (API) that makes the medicine work. Therefore, the drops contain clonazepam.


Q: What are the major conditions Rivotril drops is approved to treat?

A: The medicine is primarily approved to treat various forms of epilepsy in infants, children, and adults. Depending on the official label, specific formulations may also be indicated for treating panic disorder.


Q: Why are Rivotril drops sometimes given to children or infants?

A: The drug is specifically indicated for treating certain types of epileptic seizures in pediatric patients. Official prescribing information notes that dosing for pediatric patients is defined based on age and body weight, which the liquid formulation accommodates.


Q: Does Rivotril drops have a generic version available?

A: The active ingredient, clonazepam, is widely available in generic tablet forms manufactured by different companies. The availability of a generic liquid drop formulation may vary by country.


Q: Why are the drops specifically recommended to be mixed with liquid instead of taken straight?

A: Administration instructions state that the drops can be taken directly or mixed with a small amount of liquid like water, tea, or fruit juice. This practice may be generally accepted to help with taste masking and to facilitate accurate consumption of the prescribed amount.


Q: What types of food or drink should not be mixed with Rivotril drops?

A: Official administration instructions typically recommend mixing the drops only with a small amount of water, tea, or fruit juice. Other liquids, such as milk or carbonated beverages, are not usually listed as acceptable options.


Q: What are the most commonly reported side effects of Rivotril drops?

A: According to official product information, common side effects reported in studies include general central nervous system effects such as drowsiness, fatigue, dizziness, and problems with coordination.


Q: Is it common to feel drowsy or sleepy when starting Rivotril drops?

A: Drowsiness (somnolence) is one of the most frequently reported side effects. This effect may be most prominent when an individual first starts taking the medicine or after the dose is increased.


Q: Can Rivotril drops affect a person's ability to concentrate?

A: Official documents list potential adverse reactions that include difficulty with concentration and impaired thinking or memory. These effects are typically linked to the central nervous system activity of the medicine.


Q: Are there any long-term health issues that have been studied in people using Rivotril drops for a long time?

A: Regulatory documents address the possibility of developing tolerance (where the medicine's effect lessens over time) and the risk of physical dependence with long-term use. Official product information notes that periodic liver function tests may be considered for individuals receiving extended therapy.


Q: Is there a concern about feeling like my emotions are dulled while taking Rivotril drops?

A: Adverse reaction lists in the official product information may include reports of emotional changes such as lack of feeling or emotion or depression, which relate to an altered emotional state.


Q: Why do some people experience poor coordination or unsteadiness when taking this medicine?

A: The medicine acts on the central nervous system, and potential side effects include dizziness, unsteadiness, and problems with muscle control or coordination (ataxia). These are commonly reported during treatment.


Q: Can Rivotril drops change a person's mood or cause increased agitation?

A: Official documents describe that the medicine can be associated with changes in mood, including new or worsening depression/anxiety, irritability, and, rarely, aggressive or agitated behavior (known as paradoxical reactions).


Q: Why is it important to know if I have a lung, liver, or kidney condition before taking Rivotril drops?

A: Official warnings state that the medicine is contraindicated (should not be used) in people with significant liver disease. Caution is also advised for those with severe chronic lung disease and kidney disease, as the drug's elimination may be affected.


Q: Can Rivotril drops be used by older adults (the elderly)?

A: Information for geriatric use indicates that older patients may be more sensitive to the medicine's effects. Regulatory guidelines often suggest that lower starting doses may be appropriate for this population.


Q: Are Rivotril drops safe to take during pregnancy?

A: Official product information indicates that human data regarding use during pregnancy is limited or inconclusive. It states that the medicine should be used only if the potential benefit justifies the potential risk, and that the risks of the medicine must be weighed against the risks of an untreated medical condition.


Q: Can a mother who is breastfeeding use Rivotril drops?

A: The active substance, clonazepam, is known to be excreted into human milk. The official recommendation is to weigh the importance of the drug to the mother against the importance of breastfeeding when making a decision.


Q: Which prescription medicines are known to interact significantly with Rivotril drops?

A: Regulatory documents warn that the medicine may interact significantly with substances that also depress the central nervous system. These include opioids, alcohol, and other sedatives or hypnotics, which can increase the risk of profound sedation and serious respiratory problems.


Q: Is it true that Rivotril can become habit-forming or lead to dependence?

A: Official warnings state that the medicine exposes users to the risks of abuse, misuse, and addiction. Continued use, even as prescribed, may lead to the development of physical dependence.


Q: What is meant by 'tolerance' when talking about Rivotril drops?

A: Regulatory information defines tolerance as the phenomenon where the medicine's intended therapeutic effect diminishes or is lost after weeks or months of continuous use.


Q: What is the risk of overdose if too many Rivotril drops are accidentally taken?

A: Overdose symptoms are typically characterized by excessive central nervous system depression. Common signs include drowsiness, confusion, and impaired coordination, which may progress to coma if the overdose is severe or involves other depressant substances.


Q: What are the signs that someone might have taken too much of this medicine?

A: Signs of an overdose include severe symptoms of CNS depression such as pronounced drowsiness, slurred speech, slow reflexes, and unsteadiness. In serious cases, it can cause very slowed or stopped breathing.


Q: What kind of studies exist regarding the use of Rivotril drops in specific groups, like infants?

A: Official labels contain clinical information regarding the use of the medicine for certain seizure types in infants and children. Dosing recommendations in this population are specifically defined based on weight and age data.


Q: Have there been reports of paradoxical reactions, such as increased aggression, with Rivotril drops?

A: Paradoxical reactions have been reported in the official adverse reaction lists. These are symptoms like agitation, irritability, or increased aggression, which are the opposite of the expected calming effect.


Q: Can Rivotril drops affect sexual desire or performance?

A: The medicine's list of possible adverse effects includes reports of changes in sexual function. This may manifest as either a decreased or an increased sexual ability, desire, or performance.


Q: Is there a known link between Rivotril drops and issues like slurred speech or memory loss?

A: Official product information indicates that both slurred speech (dysarthria) and memory problems (amnesia) are listed as possible side effects associated with the medicine.


Q: Is it true that Rivotril drops might cause increased salivation in children?

A: Official product information, particularly regarding pediatric adverse reactions, notes that increased salivation (hypersalivation) can occur, especially in infants and young children.


Q: How often are blood tests recommended for people using Rivotril drops long-term?

A: Official documents indicate that periodic liver function tests may be necessary for individuals on long-term therapy or those with existing liver impairment.


Q: Is Rivotril drops a narcotic or controlled substance?

A: According to the DEA Controlled Substances Act, the medicine is classified as a Schedule IV controlled substance. This designation reflects its accepted medical use alongside a recognized potential for abuse and dependence.


Q: What is the general long-term expectation for the effectiveness of Rivotril drops for seizure disorders?

A: Regulatory warnings indicate that tolerance to the anticonvulsant effect may develop over several months in many patients. This can potentially lead to an increase in seizure frequency over time.


Q: Can Rivotril drops be taken if a person has a history of depression?

A: Official documents caution that the medicine can be associated with new or worsening depression. Regulatory documents state that due to this risk, caution is noted regarding the use of the medicine in individuals with a history of depression.


Q: Why is the medicine sometimes prescribed in drops form instead of tablets for adults?

A: The drop formulation allows for precise, flexible dosage adjustments. This is often noted as a reason for its use when initiating therapy or when complex dosing schedules are required.


Q: Is it safe to use Rivotril drops if I have a history of drug or alcohol abuse?

A: Official warnings state that the medicine is contraindicated (should not be used) if a person has a history of drug or alcohol addiction. This is due to the medicine's own potential for abuse and dependence.


Q: Can Rivotril drops cause difficulty breathing, and when should I be concerned?

A: Difficulty breathing (respiratory depression) is listed as a serious, though uncommon, adverse reaction. This risk is notably increased if the medicine is combined with other central nervous system depressants. It is also a potential sign of overdose.


Q: Do Rivotril drops affect a person's sleep quality even if they feel drowsy?

A: The list of adverse effects includes both sleepiness/drowsiness and insomnia (difficulty falling or staying asleep). This indicates that while the medicine can cause sedation, it may also affect the quality of sleep in different ways.


Q: Is an allergic reaction to Rivotril drops common, and what are the signs to look for?

A: The medicine is contraindicated in patients known to have a hypersensitivity (allergic reaction) to benzodiazepines. Signs of a serious allergic reaction to look for include rash, hives, swelling of the face, tongue, or throat, or difficulty breathing.


Q: What is the role of the active ingredient, Clonazepam, in the body's chemistry?

A: Clonazepam works by enhancing the effect of GABA, which is a natural chemical in the brain that works to inhibit or slow down nerve activity. This results in a generalized reduction of excessive electrical nerve activity in the central nervous system.


Q: Why must this medicine be kept where children cannot reach it?

A: Official patient counseling information emphasizes the need to keep this medicine secured and out of reach of children and pets. This is because accidental ingestion or misuse can lead to serious harm and death.

How should Rivotril drops be stored and disposed of?

How to Store and Dispose of Rivotril Drops?

Regulatory documents outline specific requirements for the storage, stability, and disposal of Rivotril (clonazepam) oral solution drops.

Storage Conditions

The medicine must be stored in a cool, dry place at or below 25 C or 30 C and protected from light by remaining in its original outer carton. It is mandatory to keep the container tightly closed and prevent it from freezing.

Stability and Safety

Once the bottle is first opened, the solution must be discarded after 30 days to ensure stability. For safety, the product must be stored securely out of the sight and reach of children.

Disposal Requirements

Unused or expired Rivotril drops must not be thrown away via waste water or household waste. Disposal must be performed in accordance with local regulations, and instructions should be obtained from a pharmacist.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Rivotril drops found in:

A-Z Index: